BSD Medical Corp

BSD Medical Corp (CIK 320174) leverages its Electromedical & Electrotherapeutic Apparatus heritage (SIC 3844) to deliver temperature-guided cancer therapies, primarily tabletop microwave ablation systems and supporting planning software, to hospital radiology suites, cancer centers, and interventional oncology practices seeking minimally invasive tumor control; its capital equipment is paired with service contracts, training, and consumables that keep clinicians versed in electromagnetic dosage protocols, while research partnerships sustain the product roadmap. Management keeps a close eye on reimbursement cycles, FDA labeling, and export controls because slow approvals, device efficacy scrutiny, or supply disruptions could delay deployments, which is material for a company still relying on a sparse sales cadence and a Form 8-K filed Apr 1999 for the latest disclosure event. Investors and partners tracking this specialized market should note the regulatory vigilance and niche demand drivers before counting on revenue growth, so view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025